Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison
Data up to Jan 2025
Total Citations Per Year
Abstract
References (36)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 • 16,041 citations
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 • 4,423 citations
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
2004 • 4,353 citations
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 • 2,132 citations
The Measurement of Dyspnea
1984 • 1,291 citations
Outcomes for COPD pharmacological trials: from lung function to biomarkers
2008 • 817 citations
Measurement of Symptoms, Lung Hyperinflation, and Endurance during Exercise in Chronic Obstructive Pulmonary Disease
1998 • 534 citations
Spirometric Correlates of Improvement in Exercise Performance after Anticholinergic Therapy in Chronic Obstructive Pulmonary Disease
1999 • 491 citations
In Chronic Obstructive Pulmonary Disease, a Combination of Ipratropium and Albuterol Is More Effective Than Either Agent Alone
1994 • 358 citations
Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease
2010 • 347 citations
Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD
2005 • 342 citations
Improvement in Resting Inspiratory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes *
2003 • 302 citations
Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest
2000 • 302 citations
Effects of Tiotropium With and Without Formoterol on Airflow Obstruction and Resting Hyperinflation in Patients With COPD
2006 • 284 citations
Efficacy of a new once-daily long-acting inhaled 2-agonist indacaterol versus twice-daily formoterol in COPD
2010 • 270 citations
Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis
2006 • 239 citations
Once-daily indacaterolversustwice-daily salmeterol for COPD: a placebo-controlled comparison
2010 • 212 citations
Distribution of Receptor Targets in the Lung
2004 • 204 citations
Cardiovascular Safety of Tiotropium in Patients With COPD
2009 • 183 citations
Formoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month study
2008 • 171 citations
Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison
2012 • 154 citations
Routine Nebulized Ipratropium and Albuterol Together Are Better Than Either Alone in COPD
1997 • 145 citations
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD
2011 • 139 citations
Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPD
2009 • 136 citations
Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD
2011 • 120 citations
Factor Analysis of Changes in Dyspnea and Lung Function Parameters after Bronchodilation in Chronic Obstructive Pulmonary Disease
2000 • 119 citations
QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease
2010 • 116 citations
The Safety of Tiotropium — The FDA's Conclusions
2010 • 110 citations
Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms
2010 • 99 citations
The Effect of Tiotropium on Hyperinflation and Exercise Capacity in Chronic Obstructive Pulmonary Disease
2005 • 98 citations
State of the Art Compendium: Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease
2004 • 96 citations
Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study
2011 • 96 citations
Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
2010 • 86 citations
Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease
2007 • 82 citations
Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: Systematic review with meta-analysis
2009 • 80 citations
Tiotropium HandiHaler® in the treatment of COPD: A safety review
2009 • 60 citations